Average Co-Inventor Count = 10.80
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (5 from 3,935 patents)
2. Osi Pharmaceuticals, Inc. (5 from 118 patents)
10 patents:
1. 10058534 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
2. 9931317 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
3. 9561211 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
4. 9321746 - Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
5. 8877801 - Compounds and compositions as selective estrogen receptor degraders
6. 8735405 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
7. 8101613 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
8. 7820662 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
9. 7485658 - N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors
10. 7419995 - N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library